Prophylactic use of cardiac medications for delay of left ventricular dysfunction in Duchenne muscular dystrophy

Association between prophylactic angiotensin-converting enzyme inhibitors and overall survival in Duchenne muscular dystrophy—analysis of registry data

(2021) Raphaël Porcher et al.   EUROPEAN HEART JOURNAL

Effects of cardiac medications on ventricular function in patients with Duchenne muscular dystrophy–related cardiomyopathy

(2021) Alexander P. Murphy et al.   MUSCLE & NERVE

Left ventricular dysfunction in Duchenne muscular dystrophy

(2020) Katherine A. James et al.   CARDIOLOGY IN THE YOUNG

Risk Factors for Cardiac and Non-cardiac Causes of Death in Males with Duchenne Muscular Dystrophy

(2020) Carol A. Wittlieb-Weber et al.   PEDIATRIC CARDIOLOGY

Cardiorespiratory progression over 5 years and role of corticosteroids in DMD: a single site retrospective longitudinal study

(2020) Federica Trucco et al.   CHEST

Effect and safety of treatment with ACE-inhibitor Enalapril and β-blocker metoprolol on the onset of left ventricular dysfunction in Duchenne muscular dystrophy - a randomized, double-blind, placebo-controlled trial

(2019) Sven Dittrich et al.   Orphanet Journal of Rare Diseases

Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management

(2018) David J Birnkrant et al.   LANCET NEUROLOGY

IMAGING THE HEART TO DETECT CARDIOMYOPATHY IN DUCHENNE MUSCULAR DYSTROPHY: A REVIEW

(2018) Lisa C. Power et al.   NEUROMUSCULAR DISORDERS

Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study

(2018) Tadao Aikawa et al.   PEDIATRIC CARDIOLOGY

Associations between timing of corticosteroid treatment initiation and clinical outcomes in Duchenne muscular dystrophy

(2017) Sunkyung Kim et al.   NEUROMUSCULAR DISORDERS

Predictors of Death in Adults With Duchenne Muscular Dystrophy–Associated Cardiomyopathy

(2017) Daniel Cheeran et al.   Journal of the American Heart Association

Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy

(2017) Marly Conceição Silva et al.   JAMA Cardiology

Evaluation of Echocardiographic Measures of Left Ventricular Function in Patients with Duchenne Muscular Dystrophy: Assessment of Reproducibility and Comparison to Cardiac Magnetic Resonance Imaging

(2016) Jonathan H. Soslow et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Comparison of left ventricular function assessment between echocardiography and MRI in Duchenne muscular dystrophy

(2016) Sujatha Buddhe et al.   PEDIATRIC RADIOLOGY

Contemporary Cardiac Issues in Duchenne Muscular Dystrophy: Table.

(2015) Elizabeth M. McNally et al.   CIRCULATION

Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies

(2015) Christopher F. Spurney et al.   JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY

Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial

(2015) Subha V Raman et al.   LANCET NEUROLOGY

Prevalence of Duchenne and Becker Muscular Dystrophies in the United States

(2015) P. A. Romitti et al.   PEDIATRICS

Myocardial Fibrosis Burden Predicts Left Ventricular Ejection Fraction and Is Associated With Age and Steroid Treatment Duration in Duchenne Muscular Dystrophy

(2015) A. Tandon et al.   Journal of the American Heart Association

Cooperative international neuromuscular research group duchenne natural history study demonstrates insufficient diagnosis and treatment of cardiomyopathy in duchenne muscular dystrophy

(2014) Christopher Spurney et al.   MUSCLE & NERVE

Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic Dysfunction

(2013) Srinivas R. Bapoje et al.   Circulation-Heart Failure

Oral Corticosteroids and Onset of Cardiomyopathy in Duchenne Muscular Dystrophy

(2013) Brent J. Barber et al.   JOURNAL OF PEDIATRICS

All-Cause Mortality and Cardiovascular Outcomes With Prophylactic Steroid Therapy in Duchenne Muscular Dystrophy

(2013) Gernot Schram et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Angiotensin-Converting Enzyme Inhibitors and/or Beta Blockers on the Cardiomyopathy in Duchenne Muscular Dystrophy

(2012) Laurence Viollet et al.   AMERICAN JOURNAL OF CARDIOLOGY

Carvedilol can Prevent Cardiac Events in Duchenne Muscular Dystrophy

(2010) Tsuyoshi Matsumura et al.   INTERNAL MEDICINE

Muscular Dystrophy Surveillance Tracking and Research Network (MD STARnet): Case Definition in Surveillance for Childhood-Onset Duchenne/Becker Muscular Dystrophy

(2010) Katherine D. Mathews et al.   JOURNAL OF CHILD NEUROLOGY

Hereditary muscular dystrophies and the heart

(2010) M.C.E. Hermans et al.   NEUROMUSCULAR DISORDERS

Echocardiographic Evaluation of Children With Systemic Ventricular Dysfunction Treated With Carvedilol

(2010) Colin Petko et al.   PEDIATRIC CARDIOLOGY

Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

(2009) Katharine Bushby et al.   LANCET NEUROLOGY

Effect of deflazacort on cardiac and sternocleidomastoid muscles in Duchenne muscular dystrophy: A magnetic resonance imaging study

(2008) Sophie Mavrogeni et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Beneficial effects of beta-blockers and angiotensin-converting enzyme inhibitors in Duchenne muscular dystrophy

(2008) Hitoko Ogata et al.   Journal of Cardiology

Corticosteroid treatment retards development of ventricular dysfunction in Duchenne muscular dystrophy

(2008) Larry W. Markham et al.   NEUROMUSCULAR DISORDERS

Deflazacort Use in Duchenne Muscular Dystrophy: An 8-Year Follow-Up

(2008) Sylvie Houde et al.   PEDIATRIC NEUROLOGY